Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects

PHASE3CompletedINTERVENTIONAL

Enrollment

268

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

January 31, 2013

Conditions

Ocular Inflammation

Interventions

DRUG

ISV-303

Bromfenac in DuraSite

OTHER

DuraSite Vehicle

All Listed Sponsors

lead

Sun Pharmaceutical Industries Limited

INDUSTRY

NCT01576952 - Comparison Study of ISV-303 to DuraSite Vehicle in Cataract Surgery Subjects | Biotech Hunter | Biotech Hunter